PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19717012-7	2009	CAPE treatments enhanced the expressions of glucokinase (3.4-14.9-folds), and pyruvate kinase (3.2-12.8-folds) mRNAs in diabetic rats.	caffeic acid phenethyl ester	0-4	glucokinase	Rattus norvegicus	44-55	
19717012-13	2009	CAPE exhibits a significant potential as an antidiabetic agent by suppressing hepatic glucose output via inducing mRNA expression of glucokinase and pyruvate kinase, whilst inhibiting phoshoenolpyruvate carboxykinase in diabetes.	caffeic acid phenethyl ester	0-4	glucokinase	Rattus norvegicus	133-144